Active monitoring for low-risk DCIS results in similar quality of life as standard treatment

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.

Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor

Dive Brief: Patterson Companies, a distributor of dental and animal health products, plans to sell to an investment firm for about $4.1 billion. Healthcare investment

December 11, 2024

Revolutionizing critical care: the potential of gut microbiota therapeutics

The curative potential and limitations of gut microbiome-based therapeutics in critical illnesses.

November 13, 2023

Cipla sees highest filings and grants during September in Q3 2023

Share this article Cipla has been focused on protecting inventions in Australia(AU) with 2 publications in Q3 2023 The Australia(AU) Patent Office dominates the patent

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.